Technology implementation in most of the high-tech industry has been quick and effective. This has resulted in increasing the efficiencies and reduced overall cost for these products. However, biopharmaceutical industry has been relatively slow in implementing newer technologies in the drug development lifecycle. The primary reason for this has been the requirement of highest product quality. In the recent past the industry has seen too many missteps in terms of product manufacturing that has resulted in products with unacceptable quality.  

At AT-GC, we work on the basic principle of quality by design. We have integrated quality in the product itself and not in documentation. This is primarily done by our proprietary Electronic Eye^TM technology. The technology primarily monitors a molecular fingerprint of the product throughout its life cycle. To further advance the technological development for increased efficiency, quality and consistency of the products at considerably reduced times, AT-GC BioPharm and AT-GC analytics have developed knowledge based manufacturing platform and nanotechnology based analytical platform for biopharmaceuticals. 

We at AT-GC are confident that in due course of time these technologies will become an integral part of the global biopharmaceutical industry.

At AT-GC, we've already proven we can be passionate about this business. If we hadn't been working passionately and pushing ourselves to improve each and every day, we wouldn't have survived in this intensely competitive industry. We believe that the statement: "Passionately Enabling the knowledge-based capsules", best describes what we are really doing at AT-GC. We are providing enabling products far better than our competitors – which can only be done by bringing a passion to excel to the job. The end result is not only prosperity for the investors and employees of Avanti Therapeutics, but a better quality of life for all.

Back to Vision, Mission, Values